acenaphthenequinone has been researched along with 1,10-phenanthroline-5,6-dione in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantalupo, SA; Crundwell, G; Danks, MK; Edwards, CC; Guy, RK; Hatfield, MJ; Hicks, LD; Hyatt, JL; Potter, PM; Ross, CR; Tsurkan, L; Wadkins, RM | 1 |
| Abe, T; Choshi, T; Hatae, N; Hibino, S; Ishikura, M; Nakamura, J; Okada, C; Okujima, T; Toyota, E; Uno, H; Yamada, H | 1 |
2 other study(ies) available for acenaphthenequinone and 1,10-phenanthroline-5,6-dione
| Article | Year |
|---|---|
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Carboxylic Ester Hydrolases; Crystallography, X-Ray; Glyoxal; Humans; Intestines; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship | 2007 |
Effect of the orthoquinone moiety in 9,10-phenanthrenequinone on its ability to induce apoptosis in HCT-116 and HL-60 cells.
Topics: Antineoplastic Agents; Apoptosis; HCT116 Cells; HL-60 Cells; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasms; Phenanthrenes | 2013 |